Morrison & Foerster senior partner James Brosnahan just couldn’t talk the government down.

A grand jury indicted his client, Scott Harkonen, former CEO of the Brisbane, Calif.-based biotech firm InterMune Inc., Tuesday for fraudulently marketing the company’s drug Actimmune. The decision marks a rare instance in which the Justice Department has gone criminal against an individual executive for off-label marketing abuses, rather than just reaching a deferred-prosecution agreement with the drug company.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]